Coronary atherosclerosis stabilization: an achievable goal

Area of Science:

• Cardiology
• Vascular Biology
• Preventive Medicine

Background:

• Coronary atherosclerotic plaques can cause angina, myocardial infarction, or sudden death.
• Rupture-prone plaques are lipid-rich with thin fibrous caps, often appearing mild angiographically.
• Current treatments primarily manage symptoms or salvage myocardium post-infarction, rather than preventing plaque rupture.

Purpose of the Study:

• To evaluate the impact of lipid-altering strategies on coronary artery disease progression and cardiac events in humans.
• To investigate whether modifying lipid levels can stabilize vulnerable atherosclerotic plaques.

Main Methods:

• Analysis of sixteen published angiographic regression studies.
• Review of clinical trial data assessing lipid-altering therapies for coronary artery disease.

Main Results:

• Consistently favorable alteration of lipid levels retards coronary artery disease progression.
• Lipid modification markedly reduces cardiac events.
• Observed event reduction exceeds changes seen in angiographic disease, suggesting plaque stabilization.

Conclusions:

• Lipid-altering strategies are effective in managing coronary artery disease by promoting plaque stabilization.
• Identifying patients with vulnerable plaques is critical for targeted and effective treatment.
• Early intervention with lipid modification can prevent severe cardiac events.